产品封面图
文献支持

p53-ABAI

收藏
  • ¥800
  • LSM Bio
  • 进口
  • PVT4023
  • 2025年09月20日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 保存条件

      负20摄氏度

    • 保质期

      3个月

    • 英文名

      p53-ABAI

    • 库存

      100

    • 供应商

      LSMBIO

    • 规格

      2ug

    p53-ABAI

    Search name

    p53-ABAI,Plasmid p53-ABAI,p53-ABAI vector

     

    p53-ABAI Information

    Promoter: URA3
    Replicon: pUC ori
    Plasmid classification: yeast series plasmids; yeast hybrid plasmids; single hybrid plasmids
    Plasmid size: 4944bp
    Prokaryotic resistance: ampicillin Amp (100 u g/ml)
    Screening markers: URA3
    Cloned strains of Escherichia coli, DH5 A and other Escherichia coli
    Culture conditions: 37 centigrade, aerobic LB
    Expression host: Y1Hgold and other yeast
    Culture conditions: 30 centigrade, YPDA, aerobic
    5'sequencing primers: pABAI-F (GTTCCTTATATGTAGCTTTCGACA)
    3'sequencing primers: pABAI-R (CCATCTCGAAAAAGGGTTTGCC)
    Remarks: low copy plasmids
    Use: Yeast expression

     

    p53-ABAI Description

    p53-ABAI  is a single hybrid yeast positive control plasmid. The plasmid has AbA resistance and thus has a strong screening ability, which can greatly reduce the background level.

    p53-AbAi is a yeast reporter vector that serves as a positive control in the Matchmaker Gold Yeast One-Hybrid Library Screening System. The vector contains a p53 binding site, located upstream of the yeast iso-1-cytochrome C minimal promoter and the AUR1-C gene, an antibiotic resistance gene that confers resistance to Aureobasidin A. Expression of AUR1-C, and thus AbA resistance, is induced by the binding of GAL4 activation domain-p53 fusion proteins to the p53 binding site upstream of AUR1-C.
          p53-AbAi cannot be propagated episomally in yeast; it can only be stably maintained through integration into the host genome. Integration is accomplished via homologous recombination between the vector’s URA3 gene and the nonfunctional ura3-52 locus of the yeast strain provided in the Matchmaker Gold Yeast One-Hybrid System. URA3 is a nutritional marker that can also be used for the selection of recombinant yeast. To allow propagation and selection in E. coli, the vector also contains a Col E1 origin of replication and an ampicillin resistance gene (Ampr).
         p53-AbAi is a positive control reporter vector that is designed to be used in conjunction with the autonomously replicating pGADT7-Rec vector and the p53 control cDNA provided in the Matchmaker Gold Yeast One-Hybrid Library Screening System. To perform control reactions, first linearize the p53-AbAi vector with BstBI, transform the vector into competent yeast cells, and select for integrants on SD/–Ura medium. Next, cotransform the p53 control cDNA and the SmaI-linearized pGADT7-Rec vector (provided) into competent yeast cells, and select for recombinants on SD/–Leu medium containing AbA (see the protocol in the Matchmaker Gold Yeast One-Hybrid Library Screening System User Manual  for details).
         Transformation of yeast with the linearized p53-AbAi vector will result in the integration of the vector into the yeast chromosome. Subsequent cotransformation of the linearized pGADT7-Rec vector and the p53 control cDNA will yield a construct, through the gap-repair method,that will constitutively express a GAL4 AD-p53 fusion protein. GAL4 AD-p53 will interact with the p53 binding sites on p53-AbAi and stimulate transcription of AUR1-C.
           •    Suitable host strains: DH5α and other general purpose strains.
           •    Selectable marker: plasmid confers resistance to ampicillin (100 µg/ml) to E. coli hosts.
           •    E. coli replication origin: ColE1
           •    Copy number: low

     

    p53-ABAI Sequence

     

    LOCUS       Exported                4944 bp ds-DNA     circular SYN 10-SEP-2016
    DEFINITION  synthetic circular DNA
    KEYWORDS    p53-AbAi
    SOURCE      synthetic DNA construct
      ORGANISM  synthetic DNA construct
    REFERENCE   1  (bases 1 to 4944)
      TITLE     Direct Submission
      JOURNAL   Exported Saturday, September 10, 2016
     
     
    COMMENT     Created by Clontech Laboratories Inc. http://www.clontech.com
                Cat. No. 630491
    FEATURES             Location/Qualifiers
         source          1..4944
                         /organism="synthetic DNA construct"
                         /mol_type="other DNA"
         promoter        25..83
                         /note="p53 binding site"
         misc_feature    235..1440
                         /note="Aur1-C"
                         /note="Aureobasidin Resistance"
         rep_origin      2209..2659
                         /note="pUC origin"
         misc_feature    complement(2856..3716)
                         /note="Amp(R)"
         misc_feature    complement(3925..4727)
                         /note="URA3"
    ORIGIN
            1 aagcttgaat tcgagctcgg taccaggcat gcctagcatg cctaggcatg cctaggcatg
           61 cctaggcatg cctaggcatg cctggatccc tcgaggcatg tgctctgtat gtatataaaa
          121 ctcttgtttt cttcttttct ctaaatattc tttccttata cattaggtcc tttgtagcat
          181 aaattactat acttctatag acacgcaaac acaaatacac acactaaatt aataatggca
          241 aacccttttt cgagatggtt tctatcagag agacctccaa actgccatgt agccgattta
          301 gaaacaagtt tagatcccca tcaaacgttg ttgaaggtgc aaaaatacaa acccgcttta
          361 agcgactggg tgcattacat cttcttggga tccatcatgc tgtttgtgtt cattactaat
          421 cccgcacctt ggatcttcaa gatccttttt tattgtttct tgggcacttt attcatcatt
          481 ccagctacgt cacagttttt cttcaatgcc ttgcccatcc taacatgggt ggcgctgtat
          541 ttcacttcat cgtactttcc agatgaccgc aggcctccta ttactgtcaa agtgttacca
          601 gcggtggaaa caattttata cggcgacaat ttaagtgata ttcttgcaac atcgacgaat
          661 tcctttttgg acattttagc atggttaccg tacggactat ttcattatgg ggccccattt
          721 gtcgttgctg ccatcttatt cgtatttggt ccaccaactg ttttgcaagg ttatgctttt
          781 gcatttggtt atatgaacct gtttggtgtt atcatgcaaa atgtctttcc agccgctccc
          841 ccatggtata aaattctcta tggattgcaa tcagccaact atgatatgca tggctcgcct
          901 ggtggattag ctagaattga taagctactc ggtattaata tgtatactac atgtttttca
          961 aattcctccg tcattttcgg tgcttttcct tcactgcatt ccgggtgtgc tactatggaa
         1021 gccctgtttt tctgttattg ttttccaaaa ttgaagccct tgtttattgc ttatgtttgc
         1081 tggttatggt ggtcaactat gtatctgaca caccattatt ttgtagacct tatggcaggt
         1141 tctgtgctgt catacgttat tttccagtac acaaagtaca cacatttacc aattgtagat
         1201 acatctcttt tttgcagatg gtcatacact tcaattgaga aatacgatat atcaaagagt
         1261 gatccattgg ctgcagattc aaacgatatc gaaagtgtcc ctttgtccaa cttggaactt
         1321 gactttgatc ttaatatgac tgatgaaccc agtgtaagcc cttcgttatt tgatggatct
         1381 acttctgttt ctcgttcgtc cgccacgtct ataacgtcac taggtgtaaa gagggcttaa
         1441 ggaaatccat tatgtactat ttaaaaaaca caaacttttg gatgttcggt ttattctttt
         1501 tcttttactt ttttatcatg ggagcctact tcccgttttt cccgatttgg ctacatgaca
         1561 tcaaccatat cagcaaaagt gatacgggta ttatttttgc cgctatttct ctgttctcgc
         1621 tattattcca accgctgttt ggtctgcttt ctgacaaact cggcctcgac tctagcgaat
         1681 taattcgtaa tcatgtcata gctgtttcct gtgtgaaatt gttatccgct cacaattcca
         1741 cacaacatac gagccggaag cataaagtgt aaagcctggg gtgcctaatg agtgagctaa
         1801 ctcacattaa ttgcgttgcg ctcactgccc gctttccagt cgggaaacct gtcgtgccag
         1861 ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg gcgctcttcc
         1921 gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc ggtatcagct
         1981 cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg aaagaacatg
         2041 tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct ggcgtttttc
         2101 cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca gaggtggcga
         2161 aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct cgtgcgctct
         2221 cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc gggaagcgtg
         2281 gcgctttctc atagctcacg ctgtaggtat ctcagttcgg tgtaggtcgt tcgctccaag
         2341 ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc cggtaactat
         2401 cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc cactggtaac
         2461 aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg gtggcctaac
         2521 tacggctaca ctagaagaac agtatttggt atctgcgctc tgctgaagcc agttaccttc
         2581 ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag cggtggtttt
         2641 tttgtttgca agcagcagat tacgcgcaga aaaaaaggat ctcaagaaga tcctttgatc
         2701 ttttctacgg ggtctgacgc tcagtggaac gaaaactcac gttaagggat tttggtcatg
         2761 agattatcaa aaaggatctt cacctagatc cttttaaatt aaaaatgaag ttttaaatca
         2821 atctaaagta tatatgagta aacttggtct gacagttacc aatgcttaat cagtgaggca
         2881 cctatctcag cgatctgtct atttcgttca tccatagttg cctgactccc cgtcgtgtag
         2941 ataactacga tacgggaggg cttaccatct ggccccagtg ctgcaatgat accgcgagac
         3001 ccacgctcac cggctccaga tttatcagca ataaaccagc cagccggaag ggccgagcgc
         3061 agaagtggtc ctgcaacttt atccgcctcc atccagtcta ttaattgttg ccgggaagct
         3121 agagtaagta gttcgccagt taatagtttg cgcaacgttg ttgccattgc tacaggcatc
         3181 gtggtgtcac gctcgtcgtt tggtatggct tcattcagct ccggttccca acgatcaagg
         3241 cgagttacat gatcccccat gttgtgcaaa aaagcggtta gctccttcgg tcctccgatc
         3301 gttgtcagaa gtaagttggc cgcagtgtta tcactcatgg ttatggcagc actgcataat
         3361 tctcttactg tcatgccatc cgtaagatgc ttttctgtga ctggtgagta ctcaaccaag
         3421 tcattctgag aatagtgtat gcggcgaccg agttgctctt gcccggcgtc aacacgggat
         3481 aataccgcgc cacatagcag aactttaaaa gtgctcatca ttggaaaacg ttcttcgggg
         3541 cgaaaactct caaggatctt accgctgttg agatccagtt cgatgtaacc cactcgtgca
         3601 cccaactgat cttcagcatc ttttactttc accagcgttt ctgggtgagc aaaaacagga
         3661 aggcaaaatg ccgcaaaaaa gggaataagg gcgacacgga aatgttgaat actcatactc
         3721 ttcctttttc aatattattg aagcatttat cagggttatt gtctcatgag cggatacata
         3781 tttgaatgta tttagaaaaa taaacaaata ggggttccgc gcacatttcc ccgaaaagtg
         3841 ccacctgggt aataactgat ataattaaat tgaagctcta atttgtgagt ttagtataca
         3901 tgcatttact tataatacag ttttttagtt ttgctggccg catcttctca aatatgcttc
         3961 ccagcctgct tttctgtaac gttcaccctc taccttagca tcccttccct ttgcaaatag
         4021 tcctcttcca acaataataa tgtcagatcc tgtagagacc acatcatcca cggttctata
         4081 ctgttgaccc aatgcgtctc ccttgtcatc taaacccaca ccgggtgtca taatcaacca

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    该产品被引用文献
    Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation Author:YangZhang1YiXu1WenyunLu23Jonathan M.Ghergurovich24LiliGuo56Ian A.Blair5Joshua D.Rabinowitz23XiaoluYang17 Received 22 January 2020, Revised 4 August 2020, Accepted 30 September 2020, Available online 6 November 2020. Published: November 6, 2020 Cell Metabolism Available online 6 November 2020 In Press doi: doi.org/10.1016/j.cmet.2020.10.002
    相关实验
    • 【求助】麻烦看下是野生型P53还是突变型P53

      coco0663 P53 NM_000546.4 Transcript Variant: This variant (1) is a dominant transcript and encodes isoform a. 麻烦高手看下,这是野生型P53还是突变型P53? Transcript Variant是否突变型的意思,那么NM_000546.4 所转录的是否就是突变型的P53? 谢谢 侠骨仁医

    • 【讨论】P53蛋白抗肿瘤

      whl111 P53蛋白具有肿瘤抑制作用,其机制可能是影响肿瘤细胞的凋亡。各位战友有没有想过如果将P53于体外直接作用于肿瘤细胞是不是会引起细胞的凋亡?而如果想办法让P53蛋白在体内能够接触到肿瘤细胞是不是可以起到抑制肿瘤细胞生长的作用呢? pub_wang 不太可能,其通路在肿瘤发生中已被打破,肿瘤中整个平衡都变了。 5米 一颗种子当它还是种子的时候,你把种子煮一下也许再也不会发芽,当这颗

    • 【求助】P53蛋白可以用WESTERN BLOT法测定吗

      bowenwei P53蛋白可以用WESTERN BLOT法测定吗 lnzyxyqy2003 可以啊 fangweibin119 当然可以 这个蛋白还是很好做的哦 jgl2008 请教版主,这个p53蛋白在hela细胞中的检测如何,我做了好久,均未见条带,可否赐教下呢,感谢! 忧兴逸亡 看下P53存在于细胞

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1200
    上海晶风生物科技有限公司
    2025年11月04日询价
    ¥680
    温州科淼生物科技有限公司
    2025年07月11日询价
    ¥800
    南京诺唯赞生物科技股份有限公司
    2025年12月28日询价
    询价
    NEB(北京)
    2026年01月06日询价
    询价
    上海北诺生物科技有限公司
    2025年07月16日询价
    文献支持
    p53-ABAI
    ¥800